NYSE: MOAltria Group Inc Stock
$57.80-0.75 (-1.28%)
Updated Jul 11, 2025
MO Price
$57.80
Fair Value Price
N/A
Market Cap
$97.36B
52 Week Low
$47.53
52 Week High
$61.26
P/E
9.68x
P/B
-27.74x
P/S
4.28x
PEG
N/A
Dividend Yield
7.06%
Revenue
$23.70B
Earnings
$10.21B
Gross Margin
60.5%
Operating Margin
57.58%
Profit Margin
43.1%
Debt to Equity
-11.17
Operating Cash Flow
$9B
Beta
0.3
Next Earnings
Jul 30, 2025
Ex-Dividend
N/A
Next Dividend
N/A
MO Overview
Altria Group Incorporated manufactures and sells smokeable and oral tobacco products in the U.S. The company offers cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands. It markets and sells its tobacco products to wholesalers, including distributors; and large retail organizations. Altria Group was founded in 1822 and is headquartered in Richmond, VA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MO's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Tobacco
Industry Rating
C
MO
Ranked#5 of 8
Ranked#5 of 8
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $72.26 | B | |
| $51.17 | C | |
| $179.91 | C |
Be the first to know about important MO news, forecast changes, insider trades & much more!
MO News
Overview
Due Diligence Score
–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MO scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MO is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MO is good value based on its earnings relative to its share price (9.68x), compared to the US market average (30.99x)
P/E vs Market Valuation
MO is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more MO due diligence checks available for Premium users.
Valuation
MO price to earnings (PE)
For valuing profitable companies with steady earnings
Company
9.68x
Industry
29.79x
Market
30.99x
MO is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MO is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
MO price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-27.74x
Industry
10.01x
MO's financial health
Profit margin
Revenue
$5.3B
Net Income
$1.1B
Profit Margin
20.5%
MO's Earnings (EBIT) of $13.65B... subscribe to Premium to read more.
Interest Coverage Financials
MO's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$35.8B
Liabilities
$39.2B
Debt to equity
-11.17
MO's short-term liabilities ($10.66B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MO's long-term liabilities ($28.57B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MO's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
MO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$2.7B
Investing
-$43.0M
Financing
-$1.1B
MO's operating cash flow ($8.60B)... subscribe to Premium to read more.
Debt Coverage Financials
MO vs Tobacco Stocks
Altria Group Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.